Skip to main content
Signal8

See Tai Sandi

SEC insider (Form 3/4/5 filer). CIK 0002009350. Chief Development Officer at Lexeo Therapeutics, Inc. (LXEO). 9 reported Form 4/5 transactions since Sep 2024; latest on Nov 18, 2025. Located in NEW YORK, NY.

Companies See Tai Sandi has filed insider reports for

  • Lexeo Therapeutics, Inc. (LXEO): Officer, Chief Development Officer
See Tai Sandi profile photo

See Tai Sandi

CIK: 0002009350

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Lexeo Therapeutics, Inc. logo
LXEO

Lexeo Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

  • Lexeo Therapeutics, Inc. logo
    LXEO

    Lexeo Therapeutics, Inc.

    Nov 18, 2025
    Sale
    Direct
    386 shares at avg. $9.27$4K
  • Lexeo Therapeutics, Inc. logo
    LXEO

    Lexeo Therapeutics, Inc.

    Oct 17, 2025
    Sale
    Direct
    3.8K shares at avg. $8.94$34K
  • Lexeo Therapeutics, Inc. logo
    LXEO

    Lexeo Therapeutics, Inc.

    Oct 17, 2025
    Sale
    Direct
    44 shares at avg. $9.56$420.684
  • Lexeo Therapeutics, Inc. logo
    LXEO

    Lexeo Therapeutics, Inc.

    Oct 15, 2025
    Award
    Direct
    10.9K shares-
  • Lexeo Therapeutics, Inc. logo
    LXEO

    Lexeo Therapeutics, Inc.

    Aug 18, 2025
    Sale
    Direct
    382 shares at avg. $4.67$2K
  • Lexeo Therapeutics, Inc. logo
    LXEO

    Lexeo Therapeutics, Inc.

    May 16, 2025
    Sale
    Direct
    367 shares at avg. $2.77$1K
  • Lexeo Therapeutics, Inc. logo
    LXEO

    Lexeo Therapeutics, Inc.

    Mar 14, 2025
    Award
    Direct
    5.7K shares at avg. $2.61$15K
  • Lexeo Therapeutics, Inc. logo
    LXEO

    Lexeo Therapeutics, Inc.

    Feb 19, 2025
    Sale
    Direct
    1.5K shares at avg. $4.41$7K
  • Lexeo Therapeutics, Inc. logo
    LXEO

    Lexeo Therapeutics, Inc.

    Jan 7, 2025
    Award
    Direct
    38.8K shares-

1-9 of 9